Deep learning in cancer pathology: a new generation of clinical biomarkers

A Echle, NT Rindtorff, TJ Brinker, T Luedde… - British journal of …, 2021 - nature.com
Clinical workflows in oncology rely on predictive and prognostic molecular biomarkers.
However, the growing number of these complex biomarkers tends to increase the cost and …

5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future

S Vodenkova, T Buchler, K Cervena… - Pharmacology & …, 2020 - Elsevier
Fluorouracil (5-FU) is an essential component of systemic chemotherapy for colorectal
cancer (CRC) in the palliative and adjuvant settings. Over the past four decades, several …

Colorectal cancer

E Dekker, PJ Tanis, JLA Vleugels, PM Kasi… - The Lancet, 2019 - thelancet.com
Several decades ago, colorectal cancer was infrequently diagnosed. Nowadays, it is the
world's fourth most deadly cancer with almost 900 000 deaths annually. Besides an ageing …

Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial

Q Feng, W Yuan, T Li, B Tang, B Jia, Y Zhou… - The lancet …, 2022 - thelancet.com
Background Robotic surgery for rectal cancer is gaining popularity, but evidence on long-
term oncological outcomes is scarce. We aimed to compare surgical quality and long-term …

Analysis of plasma cell-free DNA by ultradeep sequencing in patients with stages I to III colorectal cancer

T Reinert, TV Henriksen, E Christensen… - JAMA …, 2019 - jamanetwork.com
Importance Novel sensitive methods for detection and monitoring of residual disease can
improve postoperative risk stratification with implications for patient selection for adjuvant …

The American society of colon and rectal surgeons clinical practice guidelines for the management of rectal cancer

YN You, KM Hardiman, A Bafford, V Poylin… - Diseases of the Colon …, 2020 - journals.lww.com
The American Society of Colon and Rectal Surgeons (ASCRS) is dedicated to ensuring high-
quality patient care by advancing the science, prevention, and management of disorders …

Neoadjuvant (chemo) radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the multicenter …

A Ogura, T Konishi, C Cunningham… - Journal of Clinical …, 2019 - ascopubs.org
Purpose Improvements in magnetic resonance imaging (MRI), total mesorectal excision
(TME) surgery, and the use of (chemo) radiotherapy ([C] RT) have improved local control of …

International consensus recommendations on key outcome measures for organ preservation after (chemo) radiotherapy in patients with rectal cancer

E Fokas, A Appelt, R Glynne-Jones, G Beets… - Nature Reviews …, 2021 - nature.com
Multimodal treatment strategies for patients with rectal cancer are increasingly including the
possibility of organ preservation, through nonoperative management or local excision …

The multidisciplinary management of rectal cancer

DS Keller, M Berho, RO Perez, SD Wexner… - Nature Reviews …, 2020 - nature.com
Rectal cancer treatment has evolved during the past 40 years with the use of a standardized
surgical technique for tumour resection: total mesorectal excision. A dramatic reduction in …

Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in …

JP Gerard, N Barbet, R Schiappa, N Magné… - The Lancet …, 2023 - thelancet.com
Background Organ preservation after reaching clinical complete response on neoadjuvant
therapy is gaining interest for rectal cancers, although the role of radiation dose escalation is …